Increased N6-methyladenosine causes infertility is associated with FTO expression

Area of Science:

• Epigenetics
• RNA modification
• Reproductive biology

Background:

• N6-methyladenosine (m6A) is a key epigenetic regulator of the mammalian transcriptome.
• m6A demethylation is mediated by FTO and ALKBH5 proteins.
• The role of m6A in premature ovarian insufficiency (POI) remains largely unknown.

Purpose of the Study:

• To investigate the association between m6A RNA content and POI.
• To examine the expression levels of FTO and ALKBH5 in POI patients and animal models.
• To explore the potential of m6A as a biomarker for POI.

Main Methods:

• Case-controlled study involving 69 POI patients and 53 controls.
• POI mouse model utilized for ovarian tissue analysis.
• m6A content determined using an m6A test kit.
• mRNA and protein expression of FTO and ALKBH5 analyzed via qPCR and Western blot.
• FACS used for proliferation and apoptosis assays; siRNA for gene knockdown.

Main Results:

• Significantly higher m6A content observed in RNA from POI patients and mice compared to controls.
• Lower mRNA and protein expression levels of FTO detected in POI patients.
• Decreased FTO expression correlated with increased m6A levels in POI.
• POI characterized by elevated m6A RNA content.

Conclusions:

• Decreased FTO expression may lead to increased m6A levels in POI.
• Elevated m6A content is a potential biomarker for POI.
• Further investigation of high m6A as a POI biomarker is warranted.